BLADE-PCI Trial (BLADE); PHASE IIB LIPOSOMAL ALENDRONATE STUDY
Phase 2
- Conditions
- Diabetes Mellitus
- Interventions
- Drug: Saline (placebo)Drug: LABR-312
- First Posted Date
- 2016-01-05
- Last Posted Date
- 2018-01-11
- Lead Sponsor
- BIOrest Ltd.
- Target Recruit Count
- 270
- Registration Number
- NCT02645799
- Locations
- 🇮🇱
Kaplan Medical Center, Rehovot, Israel
Biorest Liposomal Alendronate With Stenting sTudy (BLAST)
Phase 2
Completed
- Conditions
- Coronary Artery Stenosis
- Interventions
- Drug: Liposomal AlendronateDrug: Saline infusion (placebo)
- First Posted Date
- 2008-08-21
- Last Posted Date
- 2016-01-20
- Lead Sponsor
- BIOrest Ltd.
- Target Recruit Count
- 226
- Registration Number
- NCT00739466
- Locations
- 🇮🇱
Western Galilee Hospital, Nahariya, Nahariya, Israel
🇮🇱Rabin Medical Center, Petah Tikva, Israel
🇮🇱Shaare Zedek Medical Center, Jerusalem, Israel
© Copyright 2025. All Rights Reserved by MedPath